PT  - JOURNAL ARTICLE
AU  - Wan, Suxin
AU  - Yi, Qingjie
AU  - Fan, Shibing
AU  - Lv, Jinglong
AU  - Zhang, Xianxiang
AU  - Guo, Lian
AU  - Lang, Chunhui
AU  - Xiao, Qing
AU  - Xiao, Kaihu
AU  - Yi, Zhengjun
AU  - Qiang, Mao
AU  - Xiang, Jianglin
AU  - Zhang, Bangshuo
AU  - Chen, Yongping
TI  - Characteristics of lymphocyte subsets and cytokines in peripheral blood of 123 hospitalized patients with 2019 novel coronavirus pneumonia (NCP)
AID  - 10.1101/2020.02.10.20021832
DP  - 2020 Jan 01
TA  - medRxiv
PG  - 2020.02.10.20021832
4099  - http://medrxiv.org/content/early/2020/02/12/2020.02.10.20021832.short
4100  - http://medrxiv.org/content/early/2020/02/12/2020.02.10.20021832.full
AB  - Background To explore the cellular immunity and cytokines status of NCP patients and to predict the correlation between the cellular immunity levels, cytokines and the severity of patients.Methods 123 NCP patients were divided into mild and severe groups. Peripheral blood was collected, lymphocyte subsets and cytokines were detected. Correlation analysis was performed on the lymphocyte subsets and cytokines, and the differences between the indexes of the two groups were analyzed.Results 102 mild and 21 severe patients were included. Lymphocyte subsets were reduced in two groups. The proportion of CD8 + T reduction in the mild and severe group was 28.43% and 61.9%, respectively; The proportion of B cell reduction was 25.49% and 28.57%; The proportion of NK cell reduction was 34.31% and 47.62%; The detection value of IL-6 was 0 in 55.88% of the mild group, mild group has a significantly lower proportion of patients with IL-6 higher than normal than severe group; There was no significant linear correlation between the lymphocyte subsets and cytokines, while significant differences were noticed between the two groups in CD4 + T, CD8 + T, IL-6 and IL-10.Conclusions Low levels of CD4+T and CD8+T are common in severe NCP. IL-6 and IL-10 levels were higher in severe patients. T cell subsets and cytokines can be used as one of the basis for predicting the transition from mild to severe. Large number of samples are still needed to confirm the “warning value” of CD4 + T, CD8 + T IL-6 and IL-10.Competing Interest StatementThe authors have declared no competing interest.Funding StatementProject No.2020CDJGRH-YJ03 supported by the Fundamental Research Funds for the Central Universities.Author DeclarationsAll relevant ethical guidelines have been followed; any necessary IRB and/or ethics committee approvals have been obtained and details of the IRB/oversight body are included in the manuscript.YesAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe datasets generated and analyzed during the current study are available from the corresponding author on reasonable request.